4.5 • 934 Ratings
🗓️ 19 May 2022
⏱️ 59 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
| 0:00.0 | I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy. |
| 0:06.1 | You can find previous podcasts and more information on a range of health topics at people's pharmacy.com. |
| 0:14.0 | In 2014, Ebola devastated three countries in West Africa. |
| 0:20.0 | What can we learn from that epidemic? |
| 0:23.0 | This is the People's Pharmacy with Terry and Joe Grady. |
| 0:27.0 | Dr. Paul Farmer was the world's best-known medical anthropologist. He was also a medical |
| 0:39.8 | doctor who worked in Haiti, Peru, and Africa. |
| 0:43.0 | Tragically, Dr. Farmer died earlier this year, |
| 0:46.0 | and we offered this show in Memoriam. |
| 0:49.0 | His organization, Partners in Health, |
| 0:51.0 | is renowned for working in under-resourced areas. |
| 0:55.0 | Despite his death, it continues working in the U.S. |
| 0:58.0 | What's it doing to help fight COVID-19? |
| 1:01.0 | Coming up on the People's Pharmacy, we talk with the author of Fevers, Feuds, and Diamonds, |
| 1:06.3 | Ebola and the Ravages of History. |
| 1:18.9 | In the people's pharmacy health headlines, doctors in the Netherlands are studying an unlikely treatment for severe COVID-19. They're giving hospitalized patients with fluid in their lungs a cancer |
| 1:26.1 | drug called Imatinib. It may be better known by its brand name Gleevick. It was one of the first breakthroughs against chronic myelogenous leukemia |
| 1:36.2 | and has transformed the treatment of other leukemia's as well, along with gastrointestinal stromal tumors. |
| 1:43.2 | Dutch doctors noted that it helps keep blood vessels from leaking when they're inflamed. |
| 1:48.2 | A placebo-controlled trial showed that COVID patients getting a matineb were less likely to die within three months. |
| 1:56.5 | They also required fewer days of invasive ventilation and less supplemental oxygen. All together, there were 385 patients with severe COVID in both arms of the study. |
| 2:07.0 | At 90 days, 9% of those on a matineb, and 16% of those on placebo had died. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.